SUBSCRIPTION AGREEMENT
This
SUBSCRIPTION AGREEMENT (this “Agreement”) made as of the date set forth on the
signature page hereof between INSITE VISION INCORPORATED, a Delaware corporation
having a place of business at 000 Xxxxxxxx Xxxxxx, Xxxxxxx, Xxxxxxxxxx 00000
(the “Company”) and the undersigned (each, a “Subscriber” and collectively, the
“Subscribers”).
W
I T N E S S E T H:
WHEREAS,
the Company desires to sell up to $6,000,000 in aggregate principal amount
of
Senior Secured Promissory Notes of the Company, the form of which is attached
hereto as Exhibit
A
(the
“Notes”), and warrants (“Warrants”) to purchase shares of common stock, par
value $0.01 per share (the “Common Stock”), of the Company to persons who
qualify as “accredited investors” as defined in Rule 501(a) of Regulation D
(“Regulation D”) promulgated under the Securities Act of 1933, as amended (the
“Securities Act”), or pursuant to Section 4(2) of the Securities Act;
and
WHEREAS,
each Subscriber desires to purchase that aggregate principal amount of Notes
and
corresponding Warrants as set forth on the signature page hereof on the terms
and conditions hereinafter set forth;
NOW,
THEREFORE, in consideration of the promises and the mutual representations
and
covenants hereinafter set forth, the parties hereto do hereby agree as
follows:
I.
|
SUBSCRIPTION
|
1.1 The
Offering.
The
Company will offer to sell to persons who qualify as “accredited investors” as
defined in Rule 501(a) of Regulation D or pursuant to Section 4(2) of the
Securities Act (the “Offering”):
(a) Notes,
which will be sold in minimum principal denominations of $500,000 (or such
other
principal amount determined in the mutual discretion of Paramount BioCapital,
Inc., as placement agent for the Offering (the “Placement Agent”) and the
Company).
(b) Each
Subscriber will also receive a Warrant to purchase 20,000 shares of Common
Stock
for each $100,000 in aggregate principal amount of Notes purchased by such
Subscriber. Each Warrant will have an exercise price equal to the volume
weighted average price of the Company’s Common Stock, as reported on the
American Stock Exchange (the “AMEX”) for the five trading days immediately prior
to the date of the applicable closing (each, a “Closing Date”), will be
exercisable for five years from the final Closing Date of the Offering (the
“Final Closing Date”), and will otherwise be in the form attached hereto as
Exhibit
B.
The
Notes, the Warrants and the shares of Common Stock issuable upon exercise of
the
Warrants (the “Warrant Shares”) are, individually and collectively, referred to
herein as the “Securities”.
1
1.2 Closing.
Upon
receipt of binding subscription agreements for at least $3,000,000 in aggregate
principal amount of Notes (the “Subscriptions”), and subject to the other terms
and conditions of this Agreement, at a time to be agreed upon by the Company
and
the Placement Agent, the Company will (a) sell to the Subscribers and the
Subscribers will purchase from the Company, the Notes and Warrants subscribed
for by each such Subscriber under the terms of the Offering (the “Closing”), and
the Subscribers will remit to the Escrow Agent (as defined in Section 1.4 below)
prior to the Closing the applicable portion of the Aggregate Purchase Price
(as
defined below) for the Closing (each, a “Closing Amount”) for release to the
Company at the Closing; (b) issue to the Placement Agent or its designees the
warrants to purchase shares of Common Stock pursuant to Section 3(a) of that
certain Placement Agent Agreement, dated December 16, 2005 (the “Placement Agent
Agreement”) by and between the Company and the Placement Agent (the “Placement
Warrants”); and (c) pay to the Placement Agent or its designees the cash
placement fees described in Section 3(a) of the Placement Agent Agreement.
The
Placement Agent will notify each Subscriber, after consultation with the
Company, as to such Subscriber’s Closing Amount (each a “Subscriber Amount”) by
providing such Subscriber with a notice substantially similar to that attached
hereto as Exhibit
D.
The
“Aggregate Purchase Price” shall mean the aggregate principal amount of Notes to
be purchased by all Subscribers at a Closing. Upon compliance with all
conditions to the Closing, the Placement Agent, with notice to the Company,
shall authorize the Escrow Agent to release the proceeds of the Closing to
the
Company, less fees and expenses due to the Placement Agent. Interest, if any,
that has accrued with respect to the Aggregate Purchase Price while in escrow
shall also be distributed to the Company at the Closing and Subscribers will
have no right to such interest.
1.3 Offering
Termination Date.
Unless
terminated earlier in the Placement Agent’s or the Company’s sole discretion,
the Offering will expire on the earlier to occur of the Closing Date and 11:59
p.m. New York City time on January 7, 2006 (subject to extension at the
Company’s and the Placement Agent’s sole discretion without notice to the
Subscribers for up to an additional 90 days) (the “Offering Termination
Date”).
1.4 Closing
Mechanics.
Prior
to the Closing, the Aggregate Purchase Price will be deposited in a segregated
escrow account with the Escrow Agent pursuant to the instructions provided
below
in this Section 1.4. Subject to the terms and conditions of this Agreement
(including, without limitation, the Company’s and the Placement Agent’s option,
each at its sole discretion, to refuse to accept Subscriptions from any
Subscriber in whole or in part), the Subscriber hereby subscribes for and agrees
to purchase from the Company the aggregate principal amount of Notes and
corresponding Warrants and the Company agrees to sell such Notes and Warrants
to
the Subscriber as is set forth upon the signature pages hereof. Pursuant to
Section 1.2, the Closing Amount, is payable by wire transfer, certified bank
check, personal check, business check (only if subscribing as an entity), or
money order made payable to “US Bank Trust National Association Corporation
Trust, (the “Escrow Agent”) F/B/O InSite Vision Incorporated.” Subscribers
paying by check should direct such check to: Xxxxx Xxxxxxxxxx, Paramount
BioCapital, Inc., 000 Xxxxxxx Xxx., 00xx Xxxxx, Xxx Xxxx, Xxx Xxxx 00000.
Subscribers paying by wire transfer should direct such wire transfer
to:
2
US
Bank Trust National Association Corporation Trust
ABA
Routing Number: 000000000
US
Bank Trust N.A.
Account
Number: 180121167365
For:
Paramount BioCapital & InSite Vision
SEI
Number: 792303000
Attn:
Xxxxxx Xxxxxxxx
Tel
# 000-000-0000
Fax
# 000-000-0000
Each
Subscriber must complete and return a duly executed, unaltered copy of this
Agreement (including the completed Confidential Subscriber Questionnaire
included in Article VIII hereof) to the Placement Agent at the Placement Agent’s
address indicated in the Memorandum on or before the date indicated by the
Placement Agent to be eligible to participate in the Offering. The Company
and
the Placement Agent retain complete discretion to accept or reject any
Subscriptions in whole or in part unless and until the Company executes a
counterpart to this Agreement that includes such Subscriber’s
signature.
1.5 Delivery
of Documents.
The
documents evidencing the Notes and Warrants purchased at the Closing will be
delivered by the Company as soon as practicable following the Final Closing
Date.
II.
|
REPRESENTATIONS,
WARRANTIES AND COVENANTS OF
SUBSCRIBERS
|
Each
Subscriber hereby represents, warrants and covenants to the Company as
follows:
2.1 The
Subscriber recognizes and acknowledges that the purchase of the Securities
involves a high degree of risk including, but not limited to, the following:
(i)
an investment in the Company is highly speculative, and only Subscribers who
can
afford the loss of their entire investment should consider investing in the
Company and the Securities; (ii) the Subscriber may not be able to liquidate
his/her/its investment; (iii) transferability of the Securities is extremely
limited; (iv) in the event of a disposition of the Securities, the Subscriber
could sustain the loss of his/its entire investment; and (v) the Company has
not
paid any dividends on its Common Stock since inception and does not anticipate
the payment of dividends in the foreseeable future.
2.2 The
Subscriber is an “accredited investor” as such term is defined in Rule 501(a) of
Regulation D as indicated by the Subscriber’s responses to the questions
contained in Article VIII hereof which responses are true and correct as of
the
date hereof and shall be true and correct as of the Closing, and that the
Subscriber is able to bear the economic risk of an investment in the Company
for
an indefinite period of time. If the Subscriber is a natural person, the
Subscriber has reached the age of majority in the state or other jurisdiction
in
which the Subscriber resides, has adequate means of providing for the
Subscriber’s current financial needs and contingencies, is able to bear the
substantial economic risks of an investment in the Securities for an indefinite
period of time, has no need for liquidity in such investment and could afford
a
complete loss of such investment. After giving effect to the purchase of the
Securities requested to be purchased by Subscriber hereunder, Subscriber
represents and warrants that Subscriber neither individually nor together as
a
group (except as permitted by Rule 13d-5(b)(2) promulgated under the Exchange
Act (as defined below)) shall own more than 19.9% of the Company’s outstanding
Common Stock or voting power.
3
2.3 i) The
Subscriber hereby acknowledges and represents that (i) the Subscriber is
knowledgeable, sophisticated and has experience in making, and is qualified
to
make, decisions with respect to investments representing an investment decision
like that involved in the purchase of the Securities hereunder and has prior
investment experience, including investment in securities which are non-listed,
unregistered and/or not traded on the NASDAQ National or SmallCap Market or
listed on AMEX; (ii) the Subscriber recognizes the highly speculative nature
of
this investment, that an investment in the Securities involves a significant
degree of risk, that the Company’s financial condition has been and continues to
be weak and the Company’s auditors have included explanatory paragraphs in the
Company’s audited financial statements for the fiscal years ended 2003 and 2004
indicating substantial doubt as to the Company’s ability to continue as a going
concern, and that the Company’s auditors will likely include a similar
explanatory paragraph in the Company’s audited financial statements for the
fiscal year ending 2005; (iii) Subscriber recognizes that that the market price
of the Common Stock of the Company has been and continues to be volatile, and
Subscriber has carefully evaluated the risks of an investment in the Securities;
and (iii) the Subscriber is able to bear the economic risk of an investment
in
the Securities and the potential loss of such investment, which risk the
Subscriber hereby assumes.
(b) Subscriber
hereby acknowledges that Subscriber has read the section of the Memorandum
entitled “Risk Factors” and understands that (i) an investment in the Securities
is a highly speculative investment, and in the event of a liquidation,
bankruptcy or insolvency of the Company, it is highly unlikely that the Company
will have sufficient assets to repay all the Notes in full; (ii) Subscribers
of
the Notes will rank pari passu with other secured creditors and as such, the
collateral securing the Notes may not be sufficient to repay the amounts due
Subscriber under the Notes; (iii) the collateral securing the Company's
obligations under the Note consists primarily of the Company's intellectual
property, the value of which is tied to the Company as a going concern and
such
collateral will generate substantially less value to secured creditors in a
liquidation than the operating value of the Company and (iv) delays, costs
and
expenses incurred in connection with any enforcement of the Collateral will
further erode the amount of funds available, if any, to repay the holders of
Notes.
2.4 The
Subscriber hereby acknowledges that he/she/it has received and carefully
reviewed this Agreement, the Confidential Private Offering Memorandum prepared
by the Company and dated as of December 27, 2005, as amended or supplemented,
including all documents attached thereto or incorporated by reference therein,
including the following documents filed by the Company with the Securities
and
Exchange Commission (the “SEC” or the “Commission”, and such documents, the “SEC
Filings”): Annual Report on Form 10-K for the year ended December 31, 2004,
filed March 31, 2005; Quarterly Report on Form 10-Q for the three months ended
March 31, 2005, filed May 16, 2005; Quarterly Report on Form 10-Q for the three
months ended June 30, 2005, filed August 15, 2005; Quarterly Report on Form
10-Q
for the three months ended September 30, 2005, filed November 14, 2005; Current
Reports on Form 8-K filed March 31, 2005, May 9, 2005, May 16, 2005, June 1,
2005, June 6, 2005, August 15, 2005, October 11, 2005, November 14, 2005 and
November 30, 2005, as well as any future filings that the Company makes with
the
SEC under Sections 13(a), 13(c), 14, or 15(d) of the Securities Exchange Act
of
1934, as amended (the “Exchange Act”), until the Offering Termination Date (as
defined herein) (the Confidential Private Offering Memorandum, including the
SEC
Filings and all other exhibits and information incorporated by reference therein
is referred to herein as the “Memorandum”). Any information that the Company
subsequently files with the SEC that is incorporated by reference will
automatically update and supersede any previous information that is part of
this
Memorandum. The Subscriber further represents that the Subscriber has been
furnished by the Company during the course of this transaction with all
information regarding the Company which the Subscriber, its investment advisor,
attorney and/or accountant has requested or desired to know or which is
otherwise relevant to an investment decision, has been afforded the opportunity
to ask questions of, and receive answers from, duly authorized officers or
other
representatives of the Company concerning the terms and conditions of the
Offering, and has received any additional information which the Subscriber
or
its advisors or agents has requested.
4
2.5 ii) The
Subscriber has relied solely upon the information in the Memorandum or provided
by the Company in making the decision to invest in the Securities. The
Subscriber is familiar with and understands the terms of the Offering, including
the rights to which the Subscriber is entitled under this Agreement. In
evaluating the suitability of an investment in the Company, the Subscriber
has
not relied upon any representation or other information (whether oral or
written) from the Company, or any agent, employee or affiliate of the Company
other than as set forth in the Memorandum, in this Agreement or resulting from
Subscriber’s own independent investigation. Subscriber understands and
acknowledges that nothing in this Agreement, the Memorandum or any other
materials provided to Subscriber in connection with the Subscription for the
Securities constitutes investment, tax or legal advice. To the extent deemed
necessary or advisable by Subscriber in his/her/its sole discretion, the
Subscriber has retained, at his/her/its sole expense, and relied upon
appropriate professional advice regarding the investment, tax and legal merits
and consequences of this Agreement and its purchase of the Securities
hereunder.
(b) The
Subscriber represents that the Securities were not offered or sold to it by
means of any form of general solicitation or general advertising, and in
connection therewith the Subscriber did not: (A) receive or review any
advertisement, article, notice or other communication published in a newspaper
or magazine or similar media or broadcast over television or radio whether
closed circuit, or generally available; or (B) attend any seminar meeting or
industry or Subscriber conference whose attendees were invited by any general
solicitation or general advertising.
2.6 The
Subscriber hereby acknowledges that neither the Offering nor the Memorandum
has
been reviewed, recommended or endorsed by the SEC or any state securities
regulatory authority or other governmental body or agency, since the Offering
is
intended to be exempt from the registration requirements of Section 5 of the
Securities Act pursuant to Regulation D. The Subscriber shall not sell or
otherwise transfer the Securities unless such transfer is registered under
the
Securities Act or unless an exemption from such registration is available.
The
Subscriber understands that if required by the laws or regulations or any
applicable jurisdictions, the Offering contemplated hereby will be submitted
to
the appropriate authorities of such state(s) for registration or exemption
therefrom and the Offering contemplated hereby will be specifically subject
to
the receipt of such registration or exemption.
5
2.7 The
Subscriber understands and acknowledges that the Securities have not been
registered under the Securities Act in reliance upon a claimed exemption under
the provisions of the Securities Act which depends, in part, upon the
Subscriber’s investment intention and the truth and accuracy of, and
Subscriber’s compliance with, the representations, warranties, acknowledgments
and covenants of Subscriber set forth herein. In this connection, the Subscriber
hereby represents that the representations, warranties, acknowledgments and
covenants of Subscriber set forth herein are true and accurate, Subscriber
will
comply with the covenants set forth herein, and the Subscriber is purchasing
the
Securities for the Subscriber’s own account for investment purposes only and not
with a view toward the resale or distribution to others and has no contract,
undertaking, agreement or other arrangement, in existence or contemplated,
to
sell, pledge, assign or otherwise transfer the Securities to any other person.
The Subscriber, if an entity, also represents that it was not formed for the
purpose of purchasing the Securities. The Subscriber has no current plans to
effect a “change of control” of the Company, as such term is understood in Rule
13d of the Exchange Act.
2.8 The
Subscriber understands that the Securities will not be registered or available
for sale in the public markets except as specifically provided herein, and
Rule
144 promulgated under the Securities Act (“Rule 144”) requires, among other
conditions, a one year holding period prior to the resale (in limited amounts)
of securities acquired in a non-public offering without having to satisfy the
registration requirements under the Securities Act. The Subscriber understands
and hereby acknowledges that the Company is under no obligation to register
any
of the Securities under the Securities Act or any state securities or “blue sky”
laws or assist the Subscriber in obtaining an exemption from various
registration requirements, other than as set forth in Article VI herein. The
Subscriber agrees to hold the Company and its directors, officers, employees,
controlling persons and agents and their respective heirs, representatives,
successors and assigns harmless and to indemnify them against all liabilities,
costs and expenses incurred by them as a result of (i) any misrepresentation
made by the Subscriber contained in this Agreement (including the Confidential
Subscriber Questionnaire contained
in Article VIII herein or otherwise furnished to the Company for purposes of
disclosure in any registration statement),
(ii) any
sale or distribution by the Subscriber in violation of the Securities Act or
any
applicable state securities or “blue sky” laws or (iii) any untrue statement of
a material fact made by the Subscriber and contained herein (including the
Confidential Subscriber Questionnaire contained in Article VIII herein or
otherwise furnished to the Company for purposes of disclosure in any
registration statement), or omission of a material fact asked for by such
questionnaire or otherwise in writing by the Company necessary to make such
statements made by the Subscriber and contained herein (including the
Confidential Subscriber Questionnaire contained in Article VIII herein), in
light of the circumstances in which they are made, not misleading.
2.9 The
Subscriber consents to the placement of a legend on any Note, certificate,
warrant or other document evidencing the Securities substantially as set forth
below, that such Securities have not been registered under the Securities Act
or
any state securities or “blue sky” laws and setting forth or referring to the
restrictions on transferability and sale thereof contained in this Agreement.
The Subscriber is aware that the Company will make a notation in its appropriate
records and with its transfer agent with respect to the restrictions on the
transferability of the Securities.
6
THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT
OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER THE SECURITIES LAWS OF ANY
STATE. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND
RESALE AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR OTHERWISE DISPOSED OF
IN
THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER
THE
SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL
IN
FORM, SUBSTANCE AND SCOPE REASONABLY SATISFACTORY TO THE COMPANY, REGISTRATION
IS NOT REQUIRED UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES
LAWS.
2.10 The
Subscriber agrees to supply the Company, as soon as practical but in no event
later than five days after the Subscriber receives the request therefore from
the Company, with such additional information concerning the Subscriber as
the
Company reasonably deems necessary or advisable.
2.11 The
Subscriber hereby represents that the address of the Subscriber furnished by
Subscriber on the signature page hereof is the Subscriber’s principal residence
if Subscriber is an individual or its principal business address if it is a
corporation or other entity.
2.12 The
Subscriber represents that (i) the Subscriber has full right, power, authority
and capacity (corporate, personal, statutory and otherwise) to execute, deliver,
and perform this Agreement and to purchase the Securities and has taken all
action necessary to authorize the execution, delivery and performance of this
Agreement; and (ii) this Agreement constitutes the legal, valid and binding
obligation of the Subscriber, enforceable against the Subscriber in accordance
with its terms.
2.13 If
the
Subscriber is a corporation, partnership, limited liability company, trust,
employee benefit plan, individual retirement account, Xxxxx Plan, or other
entity (i) it is authorized and qualified to become a Subscriber in the Company
and the person signing this Agreement on behalf of such entity has been duly
authorized by such entity to do so and (ii) it is duly organized, validly
existing and in good standing under the laws of the jurisdiction of its
organization.
2.14 The
Subscriber acknowledges that if he or she is a Registered Representative of
a
National Association of Securities Dealers, Inc. (“NASD”) member firm, he or she
must give such firm the notice required by the NASD Rules of Fair Practice,
receipt of which must be acknowledged in accordance with such
rules.
2.15 The
Subscriber understands, acknowledges and agrees with the Company that this
Subscription may be rejected, in whole or in part, by the Company or the
Placement Agent, in each of their sole and absolute discretion, at any time
before the applicable Closing Date notwithstanding prior receipt by the
Subscriber of notice of acceptance of the Subscriber’s Subscription. Only
subscriptions accepted at the applicable Closing Date shall be binding on the
Company.
7
2.16 The
Subscriber understands, acknowledges and agrees with the Company that, except
as
otherwise set forth herein, the Subscription hereunder is irrevocable by the
Subscriber, that, except as required by law, the Subscriber is not entitled
to
cancel, terminate or revoke this Agreement or any agreements of the Subscriber
hereunder and that this Agreement and such other agreements shall survive the
death or disability of the Subscriber and shall be binding upon and inure to
the
benefit of the parties and their heirs, executors, administrators, successors,
legal representatives and permitted assigns. If the Subscriber is more than
one
person, the obligations of the Subscriber hereunder shall be joint and several
and the agreements, representations, warranties and acknowledgments herein
contained shall be deemed to be made by and be binding upon each such person
and
his/her heirs, executors, administrators, successors, legal representatives
and
permitted assigns
2.17 The
Subscriber understands, acknowledges and agrees with the Company that the
Offering is intended to be exempt from registration under the Securities Act
by
virtue of Section 4(2) of the Securities Act and the provisions of Regulation
D
thereunder, which is in part dependent upon the truth, completeness and accuracy
of the statements made by the Subscriber.
2.18 The
Subscriber understands, acknowledges and agrees with the Company that, there
can
be no assurance that the Subscriber will be able to sell or dispose of the
Securities. It is understood that in order not to jeopardize the Offering’s
exempt status under Section 4(2) of the Securities Act and Regulation D, in
addition to any other restrictions on transfer set forth herein or in the
Warrants, the Company may, at a minimum, require any transferee to fulfill
the
Subscriber suitability requirements thereunder and make the representations,
warranties and covenants of Subscriber hereunder.
2.19 The
Subscriber agrees that during the period from the date that Subscriber was
first
contacted with respect to the Offering (the “First Date”) through the date upon
which the Registration Statement (as defined in Section 6.2 below) is declared
effective, the Subscriber will not directly or indirectly, through related
parties, affiliates or otherwise sell "short" or "short against the box" (as
those terms are generally understood) any equity security of the Company or
take
any action with respect to any equity security of the Company which would
violate the Securities Act or the rules and regulations promulgated thereunder
and from the First Date through the Closing Date has not and will not take
any
action the intent or reasonably foreseeable effect of which is to reduce the
trading price of the Common Stock.
2.20 The
Subscriber acknowledges and agrees that the information contained in this
Agreement, the Memorandum or otherwise made available to the Subscriber by
the
Company (collectively, the “Confidential Information”) is to be used solely for
the purpose of evaluating a possible investment in the Securities and is
confidential and non-public and agrees that all such Confidential Information
shall be kept in confidence by the Subscriber and neither used by the Subscriber
for the Subscriber’s personal benefit (other than in connection with evaluating
a possible investment in the Securities) nor disclosed to any third party for
any reason and in any manner, notwithstanding that a Subscriber’s subscription
may not be accepted by the Company; provided, however, that this obligation
shall not apply to any such Confidential Information that (i) is part of the
public knowledge or literature and readily accessible at the date hereof (except
as a result of a breach of this provision by any party), or (ii) becomes part
of
the public knowledge or literature and readily accessible by publication (except
as a result of a breach of this provision by any party).
8
2.21 If
the
Subscriber is purchasing the Securities in a fiduciary capacity for another
person or entity, including without limitation a corporation, partnership,
trust
or any other entity, the Subscriber has been duly authorized and empowered
to
execute this Agreement and all other subscription documents, and such other
person or entity fulfills all the requirements for purchase of the shares as
such requirements are set forth herein, concurs in the purchase of the
Securities and agrees to be bound by the obligations, representations,
warranties and covenants contained herein. Upon request of the Company, the
Subscriber will provide true, complete and current copies of all relevant
documents creating the Subscriber, authorizing its investment in the Company
and/or evidencing the satisfaction of the foregoing.
2.22 No
authorization, approval, consent or license of any person is required to be
obtained for the purchase of the Securities by the Subscriber, other than as
have been obtained and are in full force and effect. The execution and delivery
of this Agreement does not, and the consummation of the transactions
contemplated hereby will not, result in any violation of or constitute a default
under any Subscriber’s charter, by-laws or other organizational documents, as
applicable, or material agreement or other instrument to which the Subscriber
is
a party or by which the Subscriber or any of its properties are bound, or to
the
best of the Subscriber’s knowledge, any permit, franchise, judgment, order,
decree, statute, rule or regulation to which the Subscriber or any of its
businesses or properties is subject.
2.23 The
representations, warranties and agreements of the Subscriber contained herein,
in the Confidential Subscriber Questionnaire and in any other writing delivered
in connection with the transactions contemplated hereby shall be true and
correct in all respects on and as of the Closing Date as if made on and as
of
such date and shall survive the execution and delivery of this Agreement and
the
purchase of the Securities. Subscriber agrees to notify the Company as promptly
as possible of any change in any of the foregoing information until such time
as
the Subscriber has sold all of its Securities.
2.24 The
Subscriber hereby covenants with the Company not to make any sale of the
Securities under the Registration Statement without effectively causing the
prospectus delivery requirement under the Securities Act to be satisfied, and
further agrees to comply with reasonable requests of the Company or its transfer
agent to provide additional information and representations concerning such
sale.
2.25 Subscriber
acknowledges the following disclosure, which is set forth herein as required
pursuant to Section 25102(a) of the California Corporate Securities Law of
1968:
“THE
SALE
OF THE SECURITIES THAT ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED
WITH THE COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA AND THE
ISSUANCE OF THE SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE
CONSIDERATION THEREFOR PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE
OF SECURITIES IS EXEMPT FROM THE QUALIFICATION BY SECTION 25100, 25102, OR
25105
OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT
ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE
SALE
IS SO EXEMPT.”
9
2.26 The
Subscriber is not an adverse party to the Company in any lawsuit involving
the
Company.
III.
|
REPRESENTATIONS,
WARRANTIES AND COVENANTS BY AND OF THE
COMPANY
|
The
Company hereby represents and warrants to the Subscriber as of the date
hereof:
3.1 Organization,
Good Standing and Qualification.
The
Company is a corporation duly incorporated, validly existing and in good
standing under the laws of the State of Delaware and has full corporate power
and authority to conduct its business as currently conducted. The Company is
duly qualified as a foreign corporation to do business and is in good standing
in every jurisdiction in which the property owned or leased by it or the nature
of the business conducted by it makes such qualification necessary, except
to
the extent that the failure to be so qualified or in good standing would not
reasonably be expected to have, individually or in the aggregate, (i) a material
adverse effect on the legality, validity or enforceability of any Transaction
Document, (ii) a material adverse effect on the Company’s ability to perform in
any material respect on a timely basis its obligations under any Transaction
Document; or (iii) a material adverse effect on the business, operations,
condition (financial or otherwise), assets, properties or results of operations
of the Company and its Subsidiaries (as defined below) as a whole (any of (i),
(ii) or (iii), a “Material Adverse Effect”). For purposes hereof, “Subsidiary”
shall mean, with respect to any Person, any other Person of which more than
fifty percent (50%) of the shares of stock or other interests entitled to vote
in the election of directors or comparable Persons performing similar functions
(excluding shares or other interests entitled to vote only upon the failure
to
pay dividends thereon or other contingencies) are at the time owned or
controlled, directly or indirectly through one or more Subsidiaries, by such
Person. For purposes hereof, “Transaction Documents” shall mean this Agreement,
the Notes, the Security Agreement, the Intercreditor and Collateral Agent
Agreement, the Warrants, the Placement Warrants and the Escrow
Agreement.
3.2 Capitalization.
(a) The
authorized, issued and outstanding capital stock of the Company is as set forth
in the Memorandum, under the heading “Capitalization”. All of the securities
issued by the Company have been issued in accordance with all applicable federal
and state securities laws, and all issued and outstanding shares of Common
Stock
of the Company are validly issued, fully paid and non-assessable. Other than
as
disclosed or contemplated in the Memorandum under the heading “Capitalization”,
there are no other options, warrants, calls, rights, commitments or agreements
of any character to which the Company is a party or by which either the Company
is bound or obligating the Company to issue, deliver, sell, repurchase or
redeem, or cause to be issued, delivered, sold, repurchased or redeemed, any
shares of the capital stock of the Company or obligating the Company to grant,
extend or enter into any such option, warrant, call, right, commitment or
agreement.
10
Other
than as disclosed in the Memorandum under the heading “Capitalization” there are
no preemptive rights or rights of first refusal or similar rights which are
binding on the Company permitting any person to subscribe for or purchase from
the Company shares of its capital stock pursuant to any provision of law, the
Company’s Certificate of Incorporation as in effect on the date hereof (the
“Certificate of Incorporation”) or the Company’s By-laws, as in effect on the
date hereof (the “By-laws”) or by agreement or otherwise. Other than as
disclosed in the Memorandum under the heading “Capitalization”, there are no
securities or instruments (including, without limitation, any warrants or
convertible debentures) containing anti-dilution or similar provisions that
will
be triggered by the issuance of the Securities as described in this Agreement.
Except as provided in the Memorandum, this Agreement, in the Placement Agent
Agreement and for the selling stockholders listed in the Company’s currently
effective registration statements on Form S-3 filed on December 9, 2005 (SEC
file number 333-130248); Form S-3 filed on June 23, 2005 (SEC file number
333-126084); Form S-3 filed on June 29, 2004 (SEC filed number 333-116973);
Form
S-3 filed on June 29, 2004 (SEC filed number 333-116973); Form S-3 filed on
February 2, 2002 (SEC file number 333-54912); Form S-3 filed June 1, 2000 (SEC
file number 333-38266) and Form S-3 filed September 29, 1997 (SEC file number
333-36673), no stockholder of the Company has any right to request or require
the Company to register the sale of any shares owned by such stockholder under
the Securities Act. The Company has made available to the Placement Agent true
and correct copies of the Company’s Certificate of Incorporation and the
Company’s By-laws.
(b) The
Securities are duly authorized and, when issued and paid for in accordance
with
the applicable Transaction Documents, will be duly and validly issued, fully
paid and nonassessable, free and clear of all Liens (as defined below) imposed
by the Company other than restrictions on transfer provided for in the
Transaction Documents or by applicable law. The Warrant Shares when issued
in
accordance with the terms of the Transaction Documents, will be validly issued,
fully paid and nonassessable, free and clear of all Liens imposed by the
Company. The Company has reserved from its duly authorized capital stock a
sufficient number of shares of Common Stock for issuance of the Warrant Shares.
For purposes hereof, “Liens” shall mean and include security interests,
mortgages, liens, pledges, charges, easements, reservations, restrictions,
rights of way, servitudes, options, rights of first refusal, community property
interests, equitable interests, restrictions of any kind and all other
encumbrances, whether or not relating to the extension of credit or the
borrowing of money.
3.3 Authorization;
Enforceability.
The
Company has all requisite corporate right, power and authority to enter into
this Agreement and the other Transaction Documents and to consummate the
transactions contemplated hereby and thereby. All corporate action on the part
of the Company, its directors and stockholders necessary for the authorization,
execution, delivery and performance of this Agreement and the other Transaction
Documents by the Company, the authorization, sale, issuance and delivery of
the
Securities contemplated herein and the performance of the Company’s obligations
hereunder has been taken (other than filings as may be required to be made
with
the Commission, the NASD and AMEX and with any state or foreign blue sky or
securities regulatory authority, which filings will be made on or prior to
the
Closing or, for those filings which by their terms may be made post-Closing,
such filings will be made post-Closing within the time period prescribed for
such filings). This Agreement and the Transaction Documents have been duly
executed and delivered by the Company and constitutes a legal, valid and binding
obligation of the Company, enforceable against the Company in accordance with
their respective terms, except as enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium or similar laws affecting
creditors’ and contracting parties’ rights generally and except as
enforceability may be subject to limitations of public policy or general
principals of equity (regardless of whether such enforceability is considered
at
law or equity).
11
3.4 No
Conflict; Governmental and Other Consents.
(a) Except
as
disclosed in the Memorandum, the execution, delivery and performance by the
Company of the Transaction Documents and the consummation by the Company of
the
transactions contemplated thereby will not (i) conflict with or result in the
violation of any law, statute, rule, regulation, order, writ, injunction,
judgment or decree of any court or governmental authority to or by which the
Company or any Subsidiary is bound, (ii) conflict with or violate any provision
of the Certificate of Incorporation or By-laws of the Company or any Subsidiary,
and (iii) will not conflict with, or result in a breach or violation of, any
of
the terms or provisions of, or constitute (with due notice or lapse of time
or
both) a default under, any lease, loan agreement, mortgage, security agreement,
trust indenture or other agreement or instrument to which the Company or any
Subsidiary is a party or by which it is bound or to which any of its properties
or assets is subject, nor result in the creation or imposition of any Lien
upon
any of the properties or assets of the Company or any Subsidiary where, in
the
case of each of clauses (i) and (iii) such conflict, violation, breach, default
or imposition is reasonably likely to result in a Material Adverse
Effect.
(b) Except
as
disclosed in the Memorandum, no consent, approval, authorization or other order
of any governmental authority or other third-party is required to be made or
obtained by the Company or any Subsidiary in connection with the authorization,
execution, delivery and performance of this Agreement and the other Transaction
Documents or with the authorization, issue and sale of the Securities, except
such filings as may be required to be made with the Commission, the NASD and
AMEX and with any state or foreign blue sky or securities regulatory authority,
which filings will be made on or prior to the Closing or, for those filings
which may be made post-Closing, such filings will be made post-Closing within
the time period prescribed for such filings.
3.5 Litigation.
Other
than as disclosed in the SEC filings or the Memorandum, there is no pending
or,
to the knowledge of the Company, threatened legal or governmental proceedings
to
which the Company is a party which is reasonably expected to result in a
Material Adverse Effect or which would or might reasonably be expected to
materially adversely affect the Company’s ability to perform its obligations
under this Agreement.
12
3.6 SEC
Reports; Financial Statements.
The
Company has filed all reports, schedules, forms, statements and other documents
required to be filed by it under the Securities Act and the Exchange Act,
including pursuant to Section 13(a) or 15(d) of the Exchange Act, for the
one-year period preceding the date hereof (or such shorter period as the Company
was required by law to file such material) (the foregoing materials, including
the exhibits thereto and documents incorporated by reference therein, being
collectively referred to herein as the “SEC Reports”) on a timely basis or has
received a valid extension of such time of filing and has filed any such SEC
Reports prior to the expiration of any such extension. Except to the extent
of
any subsequent correction filed prior to the date hereof (and a copy of which
has been heretofore provided to the Purchasers), as of their respective dates,
the SEC Reports complied in all material respects with the requirements of
the
Securities Act and the Exchange Act, as applicable, and the rules and
regulations of the Commission promulgated thereunder, and none of the SEC
Reports, when filed, contained any untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary
in
order to make the statements therein, in light of the circumstances under which
they were made, not misleading. The financial statements of the Company included
in the SEC Reports, as subsequently amended and restated (provided such
amendments, if any, have been heretofore provided to the Subscribers), complied
in all material respects with applicable accounting requirements and the rules
and regulations of the Commission with respect thereto as in effect at the
time
of filing. Such financial statements have been prepared in accordance with
United States generally accepted accounting principles applied on a consistent
basis during the periods involved (“GAAP”), except as may be otherwise specified
in such financial statements or the notes thereto and except that unaudited
financial statements may not contain all footnotes required by GAAP, and fairly
present in all material respects the financial position of the Company as of
and
for the dates thereof and the results of operations and cash flows for the
periods then ended, subject, in the case of unaudited statements, to normal,
immaterial, year-end audit adjustments..
3.7 Material
Changes.
Since
the date of the latest audited financial statements included within the SEC
Reports, except as disclosed in the SEC Reports, (i) there has been no event,
occurrence or development that has had a Material Adverse Effect, (ii) the
Company has not incurred any liabilities (contingent or otherwise) other than
(A) trade payables and accrued expenses incurred in the ordinary course of
business, (B) liabilities not required to be reflected in the Company’s
financial statements pursuant to GAAP or required to be disclosed in filings
made with the Commission and (C) expenses incurred in connection with the
transactions contemplated hereunder, (iii) the Company has not altered its
method of accounting, (iv) the Company has not declared or made any dividend
or
distribution of cash or other property to its stockholders or purchased,
redeemed or made any agreements to purchase or redeem any shares of its capital
stock (other than the repurchase at cost of shares of unvested or restricted
stock as permitted under the Company’s stock option or stock purchase plan upon
termination of employment or service) and (v) the Company has not issued any
equity securities to any officer, director or Affiliate, except pursuant to
existing Company stock purchase or stock option plans.
3.8 Investment
Company.
The
Company is not, and is not an Affiliate of, and immediately after receipt of
payment for the Securities, will not be or be an Affiliate of an “investment
company” within the meaning of such term under the Investment Company Act of
1940, as amended, and the rules and regulations of the Commission
thereunder.
3.9 Public
Utility Holding Company.
The
Company is not, and after giving effect to the offering and sale of the
Securities and the applications of the proceeds thereof as described in the
Memorandum, will not be, a “holding company,” or a “subsidiary company” of a
“holding company,” or an “affiliate” of a “holding company” or of a “subsidiary
company” of a “holding company,” within the meaning of the Public Utility
Holding Company Act of 1935, as amended.
13
3.10 Use
of
Proceeds.
The
Company covenants and agrees to use the net proceeds of the Offering in the
manner as described under the heading “Use of Proceeds” in the
Memorandum.
3.11 Intellectual
Property.
(a) Schedule
3.11(a)
of this
Agreement sets forth a list of:
(i) all
United States and foreign patents and patent applications, all United States,
state and foreign trademarks, service marks and trade names for which
registrations have been issued or applied for that are owned by or to the
knowledge of the Company are subject to an obligation of assignment to the
Company; and
(ii) all
United States and foreign patents and patent applications, all United States,
state and foreign trademarks, service marks and trade names for which
registrations have been issued or applied for that are licensed to the
Company.
(b) Except
as
set forth on Schedule 3.11(b) hereof, the Company and/or its Subsidiaries owns
or possesses adequate and, to its knowledge, enforceable rights to use all
material patents, patent applications, trademarks, service marks, trade names,
logos, corporate names, copyrights, trade secrets, processes, mask works,
licenses, inventions, formulations, technology and know-how and other intangible
property currently used in the conduct of its business as described in the
Memorandum (the “Proprietary Rights”). Except as set forth on Schedule 3.11(b)
hereof, the Company and/or its Subsidiaries have taken commercially reasonable
measures to protect all of the Company’s and such Subsidiary’s Proprietary
Rights. Except as set forth on Schedule 3.11(b) hereof, neither the Company
nor
any of its Subsidiaries has received any notice of, and there are not any facts
known to the Company or any Subsidiary which indicate the existence of (i)
any
infringement or misappropriation by any third party of any of the Proprietary
Rights, which infringement or misappropriation would reasonably be expected
to
have a Material Adverse Effect, (ii) any claim by a third party contesting
the
validity of any of the Proprietary Rights, other than claims that would not
reasonably be expected to have a Material Adverse Effect or (iii) any
infringement, misappropriation or violation by the Company or any Subsidiary
or,
to the Company’s knowledge, any of their employees, of any Proprietary Rights of
third parties that would be reasonably expected to have a Material Adverse
Effect. Except as set forth on Schedule 3.11(b) hereof, to the Company's
knowledge, no infringement, illicit copying, misappropriation or violation
of
any intellectual property rights of any third party has occurred by the Company
or any of its Subsidiaries with respect to any products currently being sold
by
the Company or any Subsidiary or with respect to any products currently under
development by the Company or any Subsidiary or with respect to the conduct
of
the business of the Company or any Subsidiary as currently conducted. Except
as
set forth on Schedule 3.11(b) hereof, to the Company's knowledge, no
infringement, illicit copying, misappropriation or violation of any intellectual
property rights of any third party will occur by the Company or any of its
subsidiaries as a result of the sale by the Company or any Subsidiary of any
products currently under development by the Company should such products receive
the applicable regulatory approval for commercial sale. Except as set forth
on
Schedule 3.11(b) hereof, the Company is not aware that any of its employees,
including the employees of its subsidiaries, are obligated under any contract
(including licenses, covenants or commitments of any nature) or other agreement,
or subject to any judgment, decree or order of any court or administrative
agency, that the Company believes would materially interfere with the use of
the
employee’s best efforts to promote the interests of the Company and/or its
subsidiaries or that would conflict with the business of the Company and/or
its
subsidiaries as currently conducted. To the Company's knowledge, neither the
execution and delivery of this Agreement, nor the carrying on of the business
of
the Company and its subsidiaries by the employees of the Company and its
subsidiaries, nor the conduct of the business of the Company and its
subsidiaries, as currently conducted, will conflict with or result in a breach
of the terms, conditions or provisions of, or constitute a default under, any
contract, covenant or instrument under which any such employee is now
obligated.
14
3.12 Private
Offering.
No form
of general solicitation or general advertising was used by the Company in
connection with the Offering. Subject in part to the accuracy and completeness
of the Subscribers' representations in Article II and Article VIII of this
Agreement, no registration of the Securities pursuant to the provisions of
the
Securities Act will be required by the offer, sale, or issuance of the
Securities pursuant to this Agreement.
3.13 Transactions
With Officers and Directors.
Except
as set forth in the Memorandum, none of the officers or directors of the Company
is presently a party to any transaction with the Company (other than for
services as officers or directors), including any contract, agreement or other
arrangement providing for the furnishing of services to or by, providing for
rental of real or personal property to or from, or otherwise requiring payments
to or from any officer or director, or to the knowledge of the Company, any
entity in which any officer or director has a substantial interest or is an
officer, director, trustee or partner, in each case in excess of $60,000 other
than (i) for payment of salary or consulting fees for services rendered, (ii)
reimbursement for expenses incurred on behalf of the Company and (iii) for
other
employee benefits, including stock option agreements under any stock option
plan
of the Company.
3.14 Xxxxxxxx-Xxxxx;
Internal Accounting Controls.
Except
as set forth in the Memorandum, the Company is in compliance with all provisions
of the Xxxxxxxx-Xxxxx Act of 2002 which are applicable to it as of the Closing
Date except where the failure to comply would no be reasonably likely to result
in a Material Adverse Effect. The Company has established disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for
the Company and designed (or caused to de designed) such disclosure controls
and
procedures to ensure that material information relating to the Company was
made
known to the certifying officers by others within those entities, during the
period in which the Company’s most recently filed periodic report under the
Exchange Act was prepared. The Company’s certifying officers have evaluated the
effectiveness of the Company’s disclosure controls and procedures as of the end
covered by the period for the Company’s most recently filed periodic report
under the Exchange Act (the “Evaluation Date”). The Company disclosed in its
most recently filed periodic report under the Exchange Act the conclusions
of
the certifying officers about the effectiveness of the disclosure controls
and
procedures based on their evaluations as of the Evaluation Date. Since the
Evaluation Date, there have been no significant changes in the Company’s
internal controls (as such term is defined in Item 307(b) of Regulation S-K
under the Exchange Act).
15
3.15 Certain
Fees.
Neither
the Company nor any of its officers has retained any broker, financial advisor
or consultant, finder, placement agent, investment banker, bank or other Person
(collectively, “Intermediary”) with respect to the transactions contemplated by
this Agreement other than the Placement Agent, and the Company shall indemnify
and hold harmless the Subscribers from any liability for any compensation to
any
Intermediary (other than the Placement Agent) engaged by the Company and the
fees and expenses of defending against said liability or alleged
liability.
3.16 Private
Placement.
Assuming the accuracy of the Purchasers’ representations and warranties set
forth in Article II and Article VIII hereof, and compliance by the Placement
Agent with its obligations, (i) no registration under the Securities Act is
required for the offer and sale of the Securities to be delivered at Closing
by
the Company to the Purchasers as contemplated hereby and (ii) the issuance
and
sale of the Securities hereunder does not contravene the rules and regulations
of the AMEX.
3.17 Listing
Requirements.
The
Company’s Common Stock is registered pursuant to Section 12(g) of the Exchange
Act, and the Company has taken no action designed to, or which to its knowledge
is likely to have the effect of, terminating the registration of the Common
Stock under the Exchange Act nor has the Company received any notification
that
the Commission is contemplating terminating such registration. Except as set
forth on Schedule 3.17 hereof, the Company has not, in the 12 months preceding
the date hereof, received notice from the AMEX to the effect that the Company
is
not in compliance with the listing or maintenance requirements of the
AMEX.
3.18 Reasonably
Equivalent Value.
The
Board of Directors has determined (after internal review and discussions with
its advisors) that the terms of the Securities offered hereunder represent
the
reasonably equivalent value with respect to the sale of the Securities. The
Transaction Documents and the transactions contemplated thereby were the result
of arms' length negotiations among the parties.
3.19 Representations
Complete.
None of
the representations or warranties made by the Company in this Agreement (except
as modified by the Memorandum) and none of the statements made by the Company
in
the Memorandum contains any untrue statement of a material fact, or omits to
state any material fact necessary in order to make the statements contained
herein or therein, in the light of the circumstances under which made, not
misleading.
3.20 Tax
Status.
Except
for matters that would not, individually or in the aggregate, reasonably be
likely to have a Material Adverse Effect, the Company has filed all necessary
federal, state and foreign income and franchise tax returns and has paid or
accrued all taxes shown as due thereon, and the Company has no knowledge of
a
material tax deficiency which has been asserted or threatened against the
Company.
3.21 Foreign
Corrupt Practices.
Neither
the Company, nor to the knowledge of the Company, any agent or other person
acting on behalf of the Company, has (i) directly or indirectly, used any funds
for unlawful contributions, gifts, entertainment or other unlawful expenses
related to foreign or domestic political activity, (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any
foreign or domestic political parties or campaigns from corporate funds, (iii)
failed to disclose fully any contribution made by the Company (or made by any
person acting on its behalf of which the Company is aware) which is in violation
of law or (iv) violated in any material respect any provision of the Foreign
Corrupt Practices Act of 1977, as amended.
16
3.22 Additional
Company Covenants.
(a) The
Company will use its best efforts to obtain from its officers and directors
an
agreement that, for a period of time commencing upon the Closing until the
earlier to occur of (i) repayment of the amounts due under the Notes and (ii)
30
days from the date the Commission declares the Registration Statement effective,
they will not transfer or sell any of the Company’s securities to any party,
other than to a spouse, child, grandchild, parent, brother or sister, to a
trust
established for the benefit of the same, or to the estate of any of the same
by
gift, will or intestate succession, or pursuant to the terms of previously
granted employee stock options and previously granted outstanding warrants,
options, and convertible securities.
(b) At
the
Closing the Company shall file with the United States Patent and Trademark
Office a short-form security agreement evidencing the security interest of
the
Subscribers and the existing noteholders in the Company’s intellectual property
as set forth in the Security Agreement
IV.
|
TERMS
OF SUBSCRIPTION; CONDITIONS TO OBLIGATIONS OF THE
COMPANY
|
4.1 The
Company and the Placement Agent reserve the right to reject the subscription
made hereby in whole or in part in its sole discretion. Unless terminated
earlier in the Placement Agent’s or the Company’s sole discretion, the Offering
will expire on the Offering Termination Date.
4.2 All
funds
paid hereunder shall be deposited by each such Subscriber in escrow with the
Escrow Agent prior to the Closing, consistent with the terms of this
Agreement.
4.3 The
Subscriber hereby authorizes and directs the Company, upon the Closing, to
deliver the documents representing the Securities to be issued to the Subscriber
pursuant to this Agreement at such Closing to the residential or business
address indicated on the signature page hereto.
4.4 The
Subscriber hereby authorizes and directs the Company to return, without
interest, any funds for unaccepted subscriptions to the same account from which
the funds were drawn, including any customer account maintained with the
Placement Agent.
4.5 The
Company’s agreement with each Subscriber is a separate agreement and each sale
of the Securities to each Subscriber is a separate sale.
17
(a) In
addition to the other requirements set forth herein, the Company’s obligation to
complete the sale and issuance of the Securities and deliver such Securities
to
the Subscriber at the Closing shall be subject to the following conditions,
any
one or more of which may be waived in writing by the Company: (a) receipt by
the
Company of the aggregate principal amount of the Notes being purchased hereunder
at the Closing (less the cash placement fee due to the Placement Agent as
provided in the Placement Agent Agreement); (b) the representations, warranties,
and acknowledgements made by the Subscribers in this Agreement shall be true
and
correct when made and shall be true and correct on and as of the Closing, and
all undertakings, agreements and covenants of the Subscribers required to be
fulfilled prior to the Closing shall have been performed or complied with;
(c)
the Subscriber shall have completed, executed and delivered to the Company
the
Confidential Subscriber Questionnaire set forth in Article VIII of this
Agreement, which Questionnaire shall be true and correct as of the Closing
and
shall be satisfactory to the Placement Agent and the Company, each in their
sole
discretion; (d) there shall not then be in effect any legal or other order
enjoining or restraining the transactions contemplated by this Agreement; (e)
the sale of the Securities shall not be prohibited by any applicable law,
regulation or governmental order; (f) the Company shall have filed the required
notice with AMEX with respect to the listing of the Warrant Shares and the
Placement Warrants, (g) each of X. Xxxxx Xxxxxxxxxxxxxx and the Collateral
Agent
shall have entered into the Security Agreement, the form of which is attached
hereto as Exhibit
C
(the
“Security Agreement”) and (e) each of X. Xxxxx Xxxxxxxxxxxxxx, the Collateral
Agent and the Subscribers shall have entered into the Intercreditor and
Collateral Agency Agreement, the form of which is attached hereto as
Exhibit
E
(the
“Intercreditor Agreement”).
V.
|
CONDITIONS
TO OBLIGATIONS OF THE SUBSCRIBERS
|
5.1 Each
Subscriber’s obligations to purchase the Securities at the Closing is subject to
the fulfillment on or prior to the Closing of the following conditions, which
conditions may be waived at the option of each Subscriber to the extent
permitted by law:
(a) Representations
and Warranties Correct; Survival.
The
representations and warranties made by the Company in Article III hereof shall
be true and correct in all material respects when made (except for such
representations and warranties that are qualified by their terms by a reference
to materiality, which representations and warranties as so qualified shall
be
true and correct in all respects and for any representation or warranty that
speaks as of a specific date, which shall be true and correct in all material
respects as of such date), and shall be true and correct in all material
respects on the Closing Date with the same force and effect as if they had
been
made on and as of said date (except for any representation or warranty that
speaks as of a specific date, which shall be true and correct in all material
respects as of such date). The representations and warranties made by the
Company in Article III hereof shall survive until the first anniversary of
the
Closing Date.
(b) Covenants.
All
covenants, agreements and conditions contained in this Agreement to be performed
by the Company on or prior to the Closing shall have been performed or complied
with in all material respects.
(c) No
Legal Order Pending.
There
shall not then be in effect any legal or other order enjoining or restraining
the transactions contemplated by this Agreement.
18
(d) No
Law
Prohibiting or Restricting Such Sale.
There
shall not be in effect any law, rule or regulation prohibiting or restricting
such sale or requiring any consent or approval of any person which shall not
have been obtained to issue the Securities (except as otherwise provided in
this
Agreement). The Company shall have filed the required notice with AMEX with
respect to the listing of the Warrant Shares.
(e) Security
Agreement.
Each of
the Company, X. Xxxxx Xxxxxxxxxxxxxx and the Collateral Agent shall have
executed and delivered the Security Agreement.
(f) Intercreditor
Agreement.
Each of
X. Xxxxx Xxxxxxxxxxxxxx, the Collateral Agent and the Subscribers shall have
executed and delivered the Intercreditor Agreement.
(g) Legal
Opinion.
Counsel
for the Company, O’Melveny & Xxxxx LLP shall have furnished to a
representative of the Placement Agent and the Subscribers, an opinion, dated
as
of the Closing Date, in the form provided in the Placement Agent
Agreement.
VI.
|
REGISTRATION
RIGHTS
|
6.1 As
used
in this Agreement, the following terms shall have the following
meanings:
(a) “Affiliate”
shall mean, with respect to any Person (as defined below), any other Person
controlling, controlled by or under direct or indirect common control with
such
Person (for the purposes of this definition “control,” when used with respect to
any specified Person, shall mean the power to direct the management and policies
of such person, directly or indirectly, whether through ownership of voting
securities, by contract or otherwise; and the terms “controlling” and
“controlled” shall have meanings correlative to the foregoing).
(b) “Business
Day” shall mean a day Monday through Friday on which banks are generally open
for business in New York, New York.
(c) “Holders”
shall mean the Subscribers, the Placement Agent and any person holding
Registrable Securities or any person to whom the rights under Article VI have
been transferred in accordance with Section 6.9 hereof.
(d) “Person”
shall mean any person, individual, corporation, limited liability company,
partnership, trust or other nongovernmental entity or any governmental agency,
court, authority or other body (whether foreign, federal, state, local or
otherwise).
(e) The
terms
“register,” “registered” and “registration” refer to the registration effected
by preparing and filing a registration statement in compliance with the
Securities Act, and the declaration or ordering of the effectiveness of such
registration statement.
19
(f) “Registrable
Securities” shall mean the Common Stock issuable upon exercise of the Warrants,
and the Common Stock issuable upon exercise of the Placement Warrants;
provided,
however,
that
securities shall only be treated as Registrable Securities if and only for
so
long as they (A) have not been disposed of pursuant to a registration statement
declared effective by the Commission; (B) have not been sold in a transaction
exempt from the registration and prospectus delivery requirements of the
Securities Act so that all transfer restrictions and restrictive legends with
respect thereto are removed upon the consummation of such sale; (C) are held
by
a Holder or a permitted transferee pursuant to Section 6.9; or (D) have not
become eligible for sale pursuant to Rule 144(k) (or any successor thereto)
under the Securities Act.
(g) “Registration
Expenses” shall mean all expenses incurred by the Company in complying with
Section 6.2 hereof, including, without limitation, all registration,
qualification and filing fees, printing expenses, escrow fees, fees and expenses
of counsel for the Company, blue sky fees and expenses and the expense of any
special audits incident to or required by any such registration, and the
reasonable fees and expenses of one legal counsel for all Holders in connection
with the Registration Statement, not to exceed $3,000.
(h) “Selling
Expenses” shall mean all underwriting discounts and selling commissions
applicable to the sale of Registrable Securities and all fees and expenses
of
legal counsel and other advisors for any Holder, except for the fees and
expenses of the such counsel of the Holders as is set forth in the definition
of
“Registration Expenses” above.
6.2 Subject
to the terms herein, the Company will, as soon as practicable following the
Closing Date but not later than 30 days following the Final Closing Date (the
“Filing Date”), (a) subject to receipt of necessary information from, and
reasonable cooperation by, the Holders, file a registration statement with
the
SEC (the “Registration Statement”) on the appropriate form to allow the resale
of the Registrable Securities, and use its best efforts, subject to receipt
of
necessary information from, and reasonable cooperation by, the Holders, to
have
such Registration Statement declared effective by the SEC prior to the date
which is 120 days after the Final Closing Date; and (b) subject to Section
6.7
hereof, cause such Registration Statement to remain effective (the “Registration
Period”) until the earlier of (i) the second anniversary of the Final Closing
Date, (ii) such date as all Registrable Securities have been sold (A) pursuant
to the Registration Statement; (B) to or through a broker, dealer or underwriter
in a public distribution or a public securities transaction; and/or (C) in
a
transaction exempt from the registration and prospectus delivery requirements
of
the Securities Act under Section 4(l) thereof so that all transfer restrictions
and restrictive legends with respect thereto, if any, are removed upon the
consummation of such sale and (iii) at such time that such Registrable
Securities have become eligible for sale pursuant to Rule 144(k) (or any
successor thereto) under the Securities Act. Thereafter, the Company shall
be
entitled to withdraw the Registration Statement and the Holders shall have
no
further right to offer or sell any of the Securities pursuant to the
Registration Statement. To the extent permissible, such Registration Statement
also shall cover, to the extent allowable under the Securities Act and the
rules
promulgated thereunder (including Rule 416 under the Securities Act), such
indeterminate number of additional shares of Common Stock resulting from stock
splits, stock dividends or similar transactions with respect to the Registrable
Securities.
20
6.3 All
Registration Expenses incurred in connection with any registration,
qualification, exemption or compliance pursuant to Section 6.2 shall be borne
by
the Company. All Selling Expenses relating to the sale of securities registered
by or on behalf of Holders shall be borne by such Holders.
6.4 In
the
case of the registration, qualification, exemption or compliance effected by
the
Company pursuant to this Agreement, the Company shall, upon reasonable request,
inform each Holder as to the status of such registration, qualification,
exemption and compliance. At its expense the Company shall:
(a) subject
to Section 6.7 hereof, use its best efforts to keep such registration, and
any
qualification, exemption or compliance under state or federal securities laws
which the Company determines to obtain, continuously effective until the
termination of the Registration Period; and
(b) advise
the Holders as soon as practicable:
(i) when
the
Registration Statement or any amendment thereto has been filed with the
Commission and when the Registration Statement or any post-effective amendment
thereto has become effective;
(ii) of
the
issuance by the Commission of any stop order suspending the effectiveness of
the
Registration Statement or the initiation of any proceedings for such
purpose;
(iii) of
the
receipt by the Company of any notification with respect to the suspension of
the
qualification of the Registrable Securities included therein for sale in any
jurisdiction or the initiation or threatening of any proceeding for such
purpose; and
(iv) of
the
happening of any event that requires the making of any changes in the
Registration Statement or the prospectus so that, as of such date, the
statements therein are not misleading and do not omit to state a material fact
required to be stated therein or necessary to make the statements therein (in
the case of the prospectus, in the light of the circumstances under which they
were made) not misleading;
(c) make
every reasonable effort to obtain the withdrawal of any order suspending the
effectiveness of any Registration Statement at the earliest possible
time;
(d) at
each
Holder’s written request, furnish to each Holder, without charge, at least one
copy of such Registration Statement and any post-effective amendment thereto,
including financial statements and schedules, and, if the Holder so requests
in
writing, all exhibits (including those incorporated by reference) in the form
filed with the Commission;
21
(e) during
the Registration Period, deliver to each Holder, without charge, as many copies
of the prospectus included in such Registration Statement and any amendment
or
supplement thereto as such Holder may reasonably request in writing in order
to
facilitate the public sale or other disposition of all or any of the Securities
by Holder; and the Company consents to the use, consistent with the provisions
hereof and applicable laws, rules or regulations, of the prospectus or any
amendment or supplement thereto by each of the selling Holders of Registrable
Securities in connection with the offering and sale of the Registrable
Securities covered by the prospectus or any amendment or supplement thereto.
In
addition, upon the reasonable request of the Holder and subject in all cases
to
confidentiality protections reasonably acceptable to the Company, the Company
will meet with a Holder or a representative thereof at the Company’s
headquarters to discuss all information relevant for disclosure in the
Registration Statement covering the Registrable Securities, and will otherwise
cooperate with any Holder conducting an investigation for the purpose of
reducing or eliminating such Holder’s exposure to liability under the Securities
Act, including the reasonable production of information at the Company’s
headquarters;
(f) prior
to
any public offering of Registrable Securities pursuant to any registration
statement, register or qualify or obtain an exemption for offer and sale under
the securities or blue sky laws of such jurisdictions as any such Holders
reasonably request in writing and do any and all other reasonable acts or things
reasonably necessary or advisable to enable the offer and sale in such
jurisdictions of the Registrable Securities covered by such Registration
Statement, provided, however, that the Company shall not for any such purpose
be
required to (i) qualify to transact business as a foreign corporation in any
jurisdiction where it is not so qualified; (ii) consent to general service
of
process in any such jurisdiction; (iii) subject itself to taxation in any such
jurisdiction; (iv) provide any undertakings that cause material expense or
burden to the Company; or (v) make any change to its organizational documents
which the Board of Directors of the Company determines to be contrary to the
best interests of the Company and its stockholders;
(g) cooperate
with the Holders to facilitate the timely preparation and delivery of
certificates representing Registrable Securities to be sold pursuant to any
Registration Statement free of any restrictive legends to the extent not
required at such time and in such denominations and registered in such names
as
Holders may request at least five (5) business days prior to sales of
Registrable Securities pursuant to such Registration Statement, subject to
the
submission by Holder to the Company’s transfer agent of the original
certificate(s) representing the Registrable Securities to be sold and a separate
Subscriber’s Certificate of Subsequent Sale duly executed by Subscriber and all
other documentation reasonably required by the Company and the Company’s
transfer agent (all of which must be provided to the Company a reasonable period
of time prior to the date such Holder intends to sell such Registrable
Securities);
(h) subject
to Section 6.7 hereof, upon the occurrence of any event contemplated by Section
6.4(b)(iv) above, the Company shall promptly prepare a post-effective amendment
to the Registration Statement or a supplement to the related prospectus, or
file
any other required document so that, as thereafter promptly delivered to
purchasers of the Registrable Securities included therein, the prospectus will
not include any untrue statement of a material fact or omit to state any
material fact necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading; and
22
(i) use
its
reasonable best efforts to comply with all applicable rules and regulations
of
the Commission, and use its reasonable best efforts to make generally available
to the Holders (which may be satisfied upon filing via XXXXX) not later than
45
days (or 90 days if the fiscal quarter is the fourth fiscal quarter) after
the
end of its fiscal quarter in which the first anniversary date of the effective
date of the Registration Statement occurs, an earnings statement satisfying
the
provisions of Section 11(a) of the Securities Act.
Notwithstanding
the foregoing, it shall be a condition precedent to the obligations of the
Company to take any action pursuant to paragraphs (a) through (i) of this
Section 6.4, that the Subscriber shall furnish to the Company such information
regarding itself, the Securities to be sold by the Subscriber, and the intended
method of disposition of such Securities as shall be required to effect the
registration of the Securities, all of which information shall be furnished
to
the Company in writing specifically for use in the Registration
Statement.
6.5 The
Holders shall have no right to take any action to restrain, enjoin or otherwise
delay any registration pursuant to Section 6.2 hereof as a result of any
controversy that may arise with respect to the interpretation or implementation
of this Agreement.
6.6 iii) To
the
extent permitted by law, the Company shall indemnify each Holder and Affiliate
of each Holder, with respect to which any registration, qualification or
compliance has been effected pursuant to this Agreement, against all claims,
losses, damages and liabilities (or action in respect thereof), including any
of
the foregoing incurred in settlement of any litigation, commenced or threatened
(subject to Section 6.6(c) below), arising out of or based on any untrue
statement (or alleged untrue statement) of a material fact contained in the
Registration Statement, or any amendment or supplement thereof, incident to
any
such registration, qualification or compliance, or based on any omission (or
alleged omission) to state therein a material fact required to be stated therein
or necessary to make the statements therein not misleading, in light of the
circumstances in which they were made, and will reimburse each Holder and each
person controlling such Holder, for reasonable legal and other expenses
reasonably incurred by such Holder or person controlling such Holder in
connection with investigating or defending any such claim, loss, damage,
liability or action as incurred; provided that the Company will not be liable
in
any such case to the extent that any such claim, loss, damage, liability or
action arises out of, relates to or is based upon (i) an untrue statement or
omission made in reliance upon and in conformity with written information
furnished to the Company by or on behalf of such Holder or person controlling
such Holder and stated to be specifically for use in preparation of such
registration statement, prospectus or any supplement or amendment thereto,
or
(ii) the failure of the Holder to comply with the covenants and agreements
contained in this Agreement respecting sales of Registrable
Securities.
(b) Each
Holder will severally, if Registrable Securities held by such Holder are
included in the securities as to which such registration, qualification or
compliance is being effected, indemnify the Company, each of its directors,
officers and Agents and each Affiliate of the foregoing, against all claims,
losses, damages, liabilities and expenses (or actions in respect thereof),
including any of the foregoing incurred in settlement of any litigation,
commenced or threatened (subject to Section 6.6(c) below), arising out of or
based on any untrue statement of a material fact contained in any registration
statement, prospectus, or any amendment or supplement thereof, incident to
any
such registration, qualification or compliance, or based on any omission to
state therein a material fact required to be stated therein or necessary to
make
the statements therein not misleading, in light of the circumstances in which
they were made, in each case to the extent, but only to the extent, that such
untrue statement or omission thereof is made in reliance upon and in conformity
with written information furnished to the Company by or on behalf of the Holder
and stated to be specifically for use in preparation of such registration
statement, prospectus or any amendment or supplement thereto or is due to the
failure of the Holder to comply with the covenants and agreements contained
in
the Agreement with respect to the sale of Registrable Securities, and the Holder
will reimburse the Company, its directors and officers, and each person
controlling the Company for reasonable legal and any other expenses reasonably
incurred in connection with investigating, defending, settling, compromising
or
paying any such claim, loss, damage, liability, expense or action as incurred.
Notwithstanding the foregoing, in no event shall a Holder be liable for any
such
claims, losses, damages or liabilities in excess of the net proceeds received
by
such Holder in the Offering, except in the event of fraud or intentional
misrepresentation by such Holder.
23
(c) Each
party entitled to indemnification under this Section 6.6 (the “Indemnified
Party”) shall give notice to the party required to provide indemnification (the
“Indemnifying Party”) promptly after such Indemnified Party has actual knowledge
of any claim as to which indemnity may be sought, provided that the failure
of
any Indemnified Party to give notice as provided herein shall not relieve the
Indemnifying Party of its obligations under this Agreement, unless such failure
is materially prejudicial to the Indemnifying Party in defending such claim
or
litigation. Subject to provisions hereinafter stated, in case any such action
is
brought against any Indemnified Party and such Indemnified Party seeks or
intends to seek indemnity from an Indemnifying Party, the Indemnifying Party
will be entitled to participate in, and, to the extent that it may wish, jointly
with all other indemnifying parties similarly notified, to assume the defense
thereof with counsel reasonably satisfactory to such Indemnified Party;
provided, however, if the defendants in any such action include both the
Indemnified Party and the Indemnifying Party, and the Indemnifying Party and
the
Indemnified Party, based upon the advice of such Indemnified Party’s counsel,
shall have reasonably concluded that there may be a conflict of interest between
the positions of the Indemnifying Party and the Indemnified Party in conducting
the defense of any such action or that there may be legal defenses available
to
it and/or other indemnified parties which are different from or additional
to
those available to the Indemnifying Party, the Indemnified Party or parties
shall have the right to select separate counsel to assume such legal defenses
and to otherwise participate in the defense of such action on behalf of such
Indemnified Party or parties. Upon receipt of notice from the Indemnifying
Party
to such Indemnified Party of its election so to assume the defense of such
action and approval by the Indemnified Party of counsel, the Indemnifying Party
will not be liable to such Indemnified Party under this Section 6.6 for any
legal or other expenses subsequently incurred by such Indemnified Party in
connection with the defense thereof unless (i) the Indemnified Party shall
have
employed such counsel in connection with the assumption of legal defenses in
accordance with the proviso to the preceding sentence (it being understood,
however, that the Indemnifying Party shall not be liable for the expenses of
more than one separate counsel, approved by such Indemnifying Party representing
the Indemnified Parties who are parties to such action, or (ii) the Indemnifying
Party shall not have employed counsel reasonably satisfactory to the Indemnified
Party to represent the Indemnified Party within a reasonable time after notice
of commencement of action, in each of which cases the reasonable fees and
expenses of counsel shall be at the expense of the Indemnifying Party. In no
event shall any Indemnifying Party be liable in respect of any amounts paid
in
settlement of any action unless the Indemnifying Party shall have approved
the
terms of such settlement; provided that such approval shall not be unreasonably
withheld.
24
(d) If
the
indemnification provided for in this Section 6.6 is held by a court of competent
jurisdiction to be unavailable to an Indemnified Party with respect to any
loss,
liability, claim, damage or expense referred to therein (other than due to
the
exemptions to indemnity set forth in Section 6.6(a) above), then the
Indemnifying Party, in lieu of indemnifying such Indemnified Party thereunder,
shall contribute to the amount paid or payable by such Indemnified Party as
a
result of such loss, liability, claim, damage or expense in such proportion
as
is appropriate to reflect the relative fault of the Indemnifying Party on the
one hand and of the Indemnified Party on the other in connection with the
statements or omissions or inaccuracies in the representations and warranties
in
this Agreement which resulted in such loss, liability, claim, damage or expense
as well as any other relevant equitable considerations. The relative fault
of
the Indemnifying Party and of the Indemnified Party shall be determined by
reference to, among other things, whether the untrue or alleged untrue statement
of a material fact or the omission to state a material fact or the inaccurate
representation and/or warranty relates to information supplied by the
Indemnifying Party or by the Indemnified Party and the parties’ relative intent,
knowledge, access to information and opportunity to correct or prevent such
statement or omission. Notwithstanding the foregoing, in no event shall a Holder
be liable for any such claims, losses, damages or liabilities pursuant to this
paragraph 6.6(b) in excess of the net proceeds received by such Holder in the
Offering, except in the event of fraud or intentional misrepresentation by
such
Holder.
6.7 iv) Notwithstanding
any other provision of this Agreement, each Holder agrees that, upon receipt
of
any notice from the Company of the happening of any event requiring the
preparation of a supplement or amendment to a prospectus relating to Registrable
Securities or the filing of an appropriate report with the SEC pursuant to
the
Exchange Act, so that, as thereafter delivered to the Holders, such prospectus
shall not contain an untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary to make the statements
therein not misleading, each Holder will forthwith discontinue disposition
of
Registrable Securities pursuant to the registration statement contemplated
by
Section 6.2 until its receipt of copies of the supplemented or amended
prospectus from the Company or confirmation of the filing of such report with
the SEC by the Company, any such prospectus to be forwarded promptly to the
Subscriber by the Company, and, if so directed by the Company, each Holder
shall
deliver to the Company all copies, other than permanent file copies then in
such
Holder’s possession, of the prospectus covering such Registrable Securities
current at the time of receipt of such notice.
(b) Notwithstanding
any other provision of this Agreement, each Holder shall suspend, upon request
of the Company, any disposition of Registrable Securities pursuant to the
Registration Statement and prospectus contemplated by Section 6.2 during any
periods not to exceed 90 days in the aggregate within any one 12 month period
when the Company reasonably determines in good faith that offers and sales
pursuant thereto should not be made by reason of the presence of material
undisclosed circumstances or developments with respect to which the disclosure
that would be required in such a prospectus is premature, would have an adverse
effect on the Company or is otherwise inadvisable.
25
(c) As
a
condition to the inclusion of its Registrable Securities, each Holder shall
furnish to the Company such information regarding such Holder and the
distribution proposed by such Holder as the Company may reasonably request
in
writing or as shall be required in connection with any registration,
qualification or compliance referred to in this Article VI.
(d) Each
Holder hereby covenants with the Company not to make any sale of the Registrable
Securities without effectively causing the prospectus delivery requirements
under the Securities Act to be satisfied.
(e) Each
Holder acknowledges and agrees that the Registrable Securities sold pursuant
to
the Registration Statement described in this Section are not transferable on
the
books of the Company unless the stock certificate submitted to the transfer
agent evidencing such Registrable Securities is accompanied by a certificate
reasonably satisfactory to the Company to the effect that (i) the Registrable
Securities have been sold in accordance with such Registration Statement and
(ii) the requirement of delivering a current prospectus has been
satisfied.
(f) Each
Holder agrees not to take any action with respect to any distribution deemed
to
be made pursuant to such registration statement which would constitute a
violation of Regulation M under the Exchange Act or any other applicable rule,
regulation or law.
(g) At
the
end of the period during which the Company is obligated to keep the Registration
Statement current and effective as described above, the Holders of Registrable
Securities included in the Registration Statement shall discontinue sales of
shares pursuant to such Registration Statement upon receipt of notice from
the
Company of its intention to remove from registration the shares covered by
such
Registration Statement which remain unsold, and such Holders shall notify the
Company of the number of shares registered which remain unsold immediately
upon
receipt of such notice from the Company.
6.8 With
a
view to making available to the Holders the benefits of certain rules and
regulations of the Commission which at any time permit the sale of the
Registrable Securities to the public without registration, the Company shall
use
its reasonable best efforts to:
(a) make
and
keep public information available, as those terms are understood and defined
in
Rule 144 under the Securities Act, at all times;
(b) file
with
the Commission in a timely manner all reports and other documents required
of
the Company under the Exchange Act; and
26
(c) so
long
as a Holder owns any unregistered Registrable Securities, furnish to such
Holder, upon any reasonable written request, a written statement by the Company
as to its compliance with Rule 144 under the Securities Act, and of the Exchange
Act, a copy of the most recent annual or quarterly report of the Company, and
such other reports and documents of the Company as such Holder may reasonably
request in availing itself of any rule or regulation of the Commission allowing
a Holder to sell any such securities without registration.
6.9 The
rights to cause the Company to register Registrable Securities granted to the
Holders by the Company under Section 6.2 may be assigned in full by a Holder
in
connection with a transfer by such Holder of its Registrable Securities, but
only if: (i) such transfer may otherwise be effected in accordance with
applicable securities laws; (ii) such Holder gives prior written notice of
the
proposed transfer to the Company including the name and address of such
transferee and a copy of the transfer documents and agreements; (iii) such
transferee agrees in writing with the Company to be bound by and to comply
with
the terms and provisions of this Agreement; (iv) the transferee is an
“accredited investor” as that term is defined in Rule 501 of Regulation D; and
(v) such transfer is otherwise in compliance with this Agreement. Except as
specifically permitted by this Section 6.9, the rights of a Holder with respect
to Registrable Securities as set forth herein shall not be transferable to
any
other person, the Company may impose stop transfer orders with respect to any
such transfer or attempted transfer, and any such transfer or attempted transfer
shall be null and void.
6.10 The
Company shall use best efforts to cause all Registrable Securities covered
by a
Registration Statement to be listed on each securities exchange, interdealer
quotation system or other market on which similar securities issued by the
Company are then listed.
6.11 With
the
written consent of the Company and the Holders holding at least a majority
of
the Registrable Securities that are then outstanding, any provision of this
Article VI may be waived (either generally or in a particular instance, either
retroactively or prospectively and either for a specified period of time or
indefinitely) or amended and shall be effective against all Holders. Upon the
effectuation of each such waiver or amendment, the Company shall promptly give
written notice thereof to the Holders, if any, who have not previously received
notice thereof or consented thereto in writing.
VII.
|
MISCELLANEOUS
|
7.1 Any
notice or other communication given hereunder shall be deemed sufficient if
in
writing and sent by facsimile, with confirmation, by registered or certified
mail, return receipt requested, or delivered by hand against written receipt
therefore or sent by nationally recognized overnight express courier postage
prepaid, if to the Company: addressed to InSite Vision Incorporated, 000
Xxxxxxxx Xxxxxx, Xxxxxxx, Xxxxxxxxxx 00000, Attn: Chief Financial Officer,
Fax:
(000) 000-0000 and if to the Subscriber, at the Subscriber’s address or
facsimile number indicated on the signature page of this Agreement. Notices
shall be deemed to have been given or delivered in the case of facsimile, upon
receipt of confirmation of transmission by the sender, registered or certified
mail, three days after so mailed, in the case of hand delivery, when so
delivered against written receipt therefore, and in the case of overnight
express courier, the day after mailing, except notices of change of address,
which shall be deemed to have been given or delivered when
received.
27
7.2 Except
as
otherwise provided above, this Agreement shall not be changed, modified or
amended except by a writing signed by the parties to be charged, and this
Agreement may not be discharged except by performance in accordance with its
terms or by a writing signed by the party to be charged.
7.3 This
Agreement shall be binding upon and inure to the benefit of the parties hereto
and to their respective heirs, legal representatives, successors and assigns.
This Agreement sets forth the entire agreement and understanding between the
parties as to the subject matter hereof and merges and supersedes all prior
discussions, agreements and understandings of any and every nature among
them.
7.4 Upon
the
execution and delivery of this Agreement by the Subscriber, this Agreement
shall
become a binding obligation of the Subscriber with respect to the purchase
of
the Securities as herein provided; subject, however, to the right hereby
reserved to the Company to revoke this subscription in accordance with Section
4.1, enter into the same agreements with other subscribers and to add and/or
delete other persons as subscribers.
7.5 NOTWITHSTANDING
THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO,
THE
PARTIES EXPRESSLY AGREE THAT ALL THE TERMS AND PROVISIONS HEREOF SHALL BE
CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW YORK
WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAW. IN THE EVENT THAT A JUDICIAL
PROCEEDING IS NECESSARY, THE EXCLUSIVE FORUMS FOR RESOLVING DISPUTES ARISING
OUT
OF OR RELATING TO THIS AGREEMENT ARE EITHER THE SUPREME COURT OF THE STATE
OF
NEW YORK IN AND FOR THE COUNTY OF NEW YORK OR THE FEDERAL COURTS FOR SUCH STATE
AND COUNTY, AND ALL RELATED APPELLATE COURTS, THE PARTIES HEREBY IRREVOCABLY
CONSENT TO THE JURISDICTION OF SUCH COURTS AND AGREE TO SAID VENUE.
7.6 The
holding of any provision of this Agreement to be invalid or unenforceable by
a
court of competent jurisdiction shall not affect any other provision of this
Agreement, which shall remain in full force and effect. If any provision of
this
Agreement shall be declared by a court of competent jurisdiction to be invalid,
illegal or incapable of being enforced in whole or in part, such provision
shall
be interpreted so as to remain enforceable to the maximum extent permissible
consistent with applicable law and the remaining conditions and provisions
or
portions thereof shall nevertheless remain in full force and effect and
enforceable to the extent they are valid, legal and enforceable, and no
provisions shall be deemed dependent upon any other covenant or provision unless
so expressed herein.
7.7 It
is
agreed that a waiver by either party of a breach of any provision of this
Agreement shall not operate, or be construed, as a waiver of any subsequent
breach by that same party.
7.8 The
parties agree to execute and deliver all such further documents, agreements
and
instruments and take such other and further action as may be necessary or
appropriate to carry out the purposes and intent of this Agreement.
28
7.9 This
Agreement may be executed in two or more counterparts each of which shall be
deemed an original, but all of which shall together constitute one and the
same
instrument.
7.10 v) The
Subscribers severally agree not to issue any public statement with respect
to
the Subscribers’ investment or proposed investment in the Company or the terms
of any agreement or covenant between them and the Company without the Company’s
prior written consent, except such disclosures as may be required under
applicable law or under any applicable order, rule or regulation.
(b) The
Company agrees not to disclose the names, addresses or any other information
about the Subscribers, except as required by law and to satisfy its obligations
under Article VI.
7.11 The
Subscriber represents and warrants that it has not engaged, consented to nor
authorized any broker, finder or intermediary to act on its behalf, directly
or
indirectly, as a broker, finder or intermediary in connection with the
transactions contemplated by this Agreement. Subscriber hereby severally agrees
to indemnify and hold harmless the Company from and against all fees,
commissions or other payments owing to any such person or firm acting on behalf
of such Subscriber hereunder.
7.12 Nothing
in this Agreement shall create or be deemed to create any rights in any person
or entity not a party to this Agreement, except for the holders of Registrable
Securities.
7.13 The
Company acknowledges and agrees that irreparable damage would occur in the
event
that any of the provisions of Article VI of this Agreement were not performed
in
accordance with its specific terms or were otherwise breached and that such
damage would not be compensable in money damages and that it would be extremely
difficult or impracticable to measure the resultant damages. Accordingly, except
as otherwise specifically set forth herein, any Subscriber shall be entitled
to
an injunction or injunctions with respect to the provisions of this Agreement
and to enforce specifically the terms and provisions hereof, in addition to
any
other remedy to which it may be entitled at law or in equity, and the Company
expressly waives any defense that a remedy in damages would be adequate and
expressly waives any requirement in an action for specific performance for
the
posting of a bond by the Subscriber bringing such action.
[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]
29
VIII.
|
CONFIDENTIAL
SUBSCRIBER QUESTIONNAIRE
|
The
Subscriber represents and warrants that he, she or it comes within one category
marked below, and that for any category marked, he, she or it has truthfully
set
forth, where applicable, the factual basis or reason the Subscriber comes within
that category. ALL INFORMATION IN RESPONSE TO THIS PARTS I-IV OF THIS
QUESTIONNAIRE WILL BE KEPT STRICTLY CONFIDENTIAL except as otherwise required
by
law or as necessary for inclusion in the Registration Statement. The undersigned
agrees to furnish any additional information which the Company deems necessary
in order to verify the answers set forth below.
Category
A ___
|
The
undersigned is an individual (not a partnership, corporation, etc.)
whose
individual net worth, or joint net worth with his or her spouse,
presently
exceeds $1,000,000.
|
Explanation.
In calculating net worth you may include equity in personal property and
real
estate, including your principal residence, cash, short term investments,
stock
and securities. Equity in personal property and real estate should be based
on
the fair market value of such property less debt secured by such
property.
Category
B ___
|
The
undersigned is an individual (not a partnership, corporation, etc.)
who
had an income in excess of $200,000 in each of the two most recent
years,
or joint income with his or her spouse in excess of $300,000 in
each of
those years (in each case including foreign income, tax exempt
income and
full amount of capital gains and losses but excluding any income
of other
family members and any unrealized capital appreciation) and has
a
reasonable expectation of reaching the same income level in the
current
year
|
Category
C ___
|
The
undersigned is a director or executive officer of the Company which
is
issuing and selling the Securities
|
Category
D ___
|
The
undersigned is a bank; a savings and loan association; insurance
company;
registered investment company; registered business development
company;
licensed small business investment company (“SBIC”);
or employee benefit plan within the meaning of Title 1 of ERISA
and (a)
the investment decision is made by a plan fiduciary which is either
a
bank, savings and loan association, insurance company or registered
investment advisor, or (b) the plan has total assets in excess
of
$5,000,000 or (c) is a self directed plan with investment decisions
made
solely by persons that are accredited investors. (describe
entity)
|
30
Category
E ___
|
The
undersigned is a private business development company as defined
in
section 202(a)(22) of the Investment Advisors Act of 1940. (describe
entity)
|
Category
F ___
|
The
undersigned is either a corporation, partnership, Massachusetts
business
trust, or non profit organization within the meaning of Section
501(c)(3)
of the Internal Revenue Code, in each case not formed for the specific
purpose of acquiring the Securities and with total assets in excess
of
$5,000,000. (describe entity)
|
Category
G ___
|
The
undersigned is a trust with total assets in excess of $5,000,000,
not
formed for the specific purpose of acquiring the Securities, where
the
purchase is directed by a “sophisticated Subscriber“ as defined in
Regulation 506(b)(2)(ii) under the Securities Act.
|
Category
H ___
|
The
undersigned is an entity (other than a trust) in which all of the
equity
owners are “accredited investors” within one or more of the above
categories. If relying upon this category alone, each equity owner
must
complete a separate copy of this Agreement. (describe entity)
|
Category
I ____
|
The
undersigned is not within any of the categories above and is therefore
not
an accredited investor.
|
The
undersigned agrees that the undersigned will notify the Company at any time
on
or prior to the Closing Date in the event that the representations and
warranties in this Agreement shall cease to be true, accurate and
complete.
Part
II
SUITABILITY
(please
answer each question)
(a) For
an
individual Subscriber, please describe your current employment, including the
company by which you are employed and its principal business:
31
(b) For
an
individual Subscriber, please describe any college or graduate degrees held
by
you:
(c) For
all
Subscribers, please state whether you have you participated in other private
placements before:
YES_______ NO_______
(d) If
your
answer to question (d) above was “YES”, please indicate frequency of such prior
participation in private placements of:
Public
Companies
|
Private
Companies
|
Public
or Private Pharmaceutical Companies
|
|
Frequently
|
_________
|
__________
|
_________
|
Occasionally
|
_________
|
__________
|
_________
|
Never
|
_________
|
_________
|
__________
|
(e) For
individual Subscribers, do you expect your current level of income to
significantly decrease in the foreseeable future:
YES_______ NO_______
(f) For
trust, corporate, partnership and other institutional Subscribers, do you expect
your total assets to significantly decrease in the foreseeable
future:
YES_______ NO_______
(g) For
all
Subscribers, do you have any other investments or contingent liabilities which
you reasonably anticipate could cause you to need sudden cash requirements
in
excess of cash readily available to you:
YES_______ NO_______
(h) For
all
Subscribers, are you familiar with the risk aspects and the non-liquidity of
investments such as the securities for which you seek to subscribe?
YES_______ NO_______
(i) For
all
Subscribers, do you understand that there is no guarantee of financial return
on
this investment, that an investment in the Securities is highly speculative
and
risky and that you run the risk of losing your entire investment?
YES_______ NO_______
32
(j) For
all
Subscribers, will you have sufficient readily available cash to fund your
obligation to purchase Securities at the Closing pursuant to your subscription
if and when the Closing occurs?
YES_______ NO_______
Part
III MANNER
IN
WHICH TITLE IS TO BE HELD. (circle one)
(a) Individual
Ownership
(b) Community
Property
(c) Joint
Tenant with Right of
Survivorship
(both parties
must
sign)
(d) Partnership*
(e) Tenants
in Common
(f) Company*
(g) Trust*
(h) Other
*If
Securities are being subscribed for by an entity, the attached Certificate
of
Signatory must also be completed.
Part
IV NASD
AFFILIATION.
Are
you
affiliated or associated with an NASD member firm (please check
one):
Yes
_________ No
__________
If
Yes,
please describe:
_________________________________________________________
_________________________________________________________
_________________________________________________________
*If
Subscriber is a registered representative with an NASD member firm, have the
following acknowledgment signed by the appropriate party:
The
undersigned NASD member firm acknowledges receipt of the notice required by
Article III, Sections 28(a) and (b) of the Rules of Fair Practice.
_________________________________
Name
of
NASD Member Firm
By:
______________________________
Authorized
Officer
Date:
____________________________
33
Part
V
REGISTRATION
QUESTIONNAIRE
The
following questions in this Part V are specifically intended to provide
information to the Company for the Company's use in the preparation of the
Registration Statement contemplated by the Subscription Agreement and for
specific inclusion in such Registration Statement.
PLEASE
ANSWER EVERY QUESTION BELOW. If a question is inapplicable to you or your answer
is in the negative, please so state by inserting “N/A.” If you are in doubt
whether a particular question requires an affirmative response from you, please
furnish full particulars so that those persons responsible for preparing the
Registration Statement contemplated by the Subscription Agreement can determine
whether any disclosure based on your answer is required. Information requested
in this questionnaire is as of the date you complete the questionnaire, unless
otherwise indicated. Your furnishing such information does not necessarily
mean
that such information will be disclosed, although it may be disclosed.
You
are required to promptly provide the Company with any update to the information
if such information changes after the date hereof.
DEFINITIONS
Your
answers to this questionnaire should be made upon the basis of the following
definitions of terms used in this questionnaire:
The
term
“beneficial
owner”
of
a
security includes any person who, directly or indirectly, through any contract,
arrangement, understanding, relationship or otherwise has or shares (1) voting
power, which includes the power to vote, or direct the voting of, such security
or (2) investment power, which includes the power to dispose or direct the
disposition of such security. A person may be regarded as having voting power
of
a security which is owned (i) by his spouse or minor children or by any of
his
relatives or his spouse’s relatives who share the same home with him, (ii) a
partnership of which he is a partner or (iii) a corporation of which he is
a
substantial stockholder. A person is also deemed to be the beneficial owner
of
shares which that person has the right to acquire within 60 days, including
but
not limited to any right to acquire through the exercise of an option, through
conversion of a security, pursuant to the power to revoke a trust or pursuant
to
the automatic termination of a trust. Please also disclose any other rights
which you have to acquire securities of the Company on or before July 31,
2006.
The
term
“material,”
when
used to qualify a requirement for the furnishing of information as to any
subject, limits the information required to those matters about which the
average prudent investor should reasonably be informed before buying or selling
the securities of the Company. If you are in doubt as to the materiality of
certain information, you should relate sufficient facts to enable the Company
and its advisors to reach a conclusion as to its materiality.
34
QUESTIONS
QUESTION
1:
State
your present position or positions with the Company (if any), including
membership on any audit, personnel, compensation or similar committee or
committees; any positions held by you during the previous three years; and
any
positions to which you have been elected or appointed but the duties of which
you have not yet assumed. For each position, list the term or expected term
of
office.
ANSWER:
QUESTION
2:
Other
than Securities that you will acquire in connection with the
Offering,
provide
below information regarding the equity securities of the Company of which you
are the “beneficial owner.” Please
refer to the definition of “beneficial owner,” above.
Under
the column “Nature of Ownership,” please indicate amounts of securities for
which you have (a) sole voting power, (b) shared voting power, (c) sole
investment power, or (d) shared investment power. If your response covers any
securities included because you have the right to acquire them on or before
July
31, 2006, please separately indicate the amount of such securities. Also, if
you
hold more than 5% of the Company’s securities pursuant to a voting trust or
similar agreement, please separately state the amount of such securities held
or
to be held pursuant to the trust or agreement, the duration of the agreement
and
the names and addresses of the voting trustees, outlining briefly their voting
rights and other powers under the trust or agreement.
ANSWER
(attach additional pages if necessary):
Number
of Nature
of
Securities Ownership Title
of Securities
QUESTION
3:
If
you
plan to offer your shares of Common Stock through the selling efforts of brokers
or dealers, describe the terms (and attach copies) of any agreement,
arrangement, or understanding entered into with broker(s) or dealer(s),
including volume limitations on sales, parties to the agreement and the
conditions under which the agreement may be terminated. If known, identify
the
broker(s) or dealer(s), which will participate in the offering and state the
amount to be offered through each.
ANSWER:
35
QUESTION
4:
Describe
below any information known to you, and if none state “none,” pertaining to
underwriting compensation and arrangements or any dealings between any
underwriter or related person, member of the NASD or a person associated with
a
member of the NASD, and the Company or any controlling stockholder thereof
since
January 1, 2002.
ANSWER:
QUESTION
5:
State
below whether you or any of your associates are a member of NASD, a controlling
stockholder of a member, a person associated or affiliated with a member or
an
underwriter or related person with respect to the proposed offering. If you
responded “yes,” describe such relationship:
ANSWER:
QUESTION
6:
Are
you a
broker-dealer?
ANSWER:
Yes
______ No______
QUESTION
7:
If
you
are not a broker-dealer, are you affiliated with a broker-dealer?
ANSWER:
Yes
______ No______
QUESTION
8:
If
you
are affiliated with a broker-dealer, did you purchase the securities in the
ordinary course of business?
ANSWER:
Yes
______ No______
36
QUESTION
9:
If
you
are affiliated with a broker-dealer, did you have any agreements or
understandings, directly or indirectly, with any person to distribute the
securities at the time that you purchased the securities?
ANSWER:
Yes
______ No______
Please
note that the Commission takes the position that if you are a broker-dealer,
you
are to be identified in the Registration Statement as an underwriter. In the
“Plan of Distribution,” the Registration Statement will provide substantially as
follows:
“The
selling stockholders and any broker-dealers, agents or underwriters that
participate with the selling stockholders in the distribution of the issued
and
outstanding shares of common stock or the shares of stock issuable upon exercise
of warrants may be deemed to be "underwriters" within the meaning of the
Securities Act, in which event any commissions received by these broker-dealers,
agents or underwriters and any profits realized by the selling stockholders
on
the resales of the securities may be deemed to be underwriting commissions
or
discounts under the Securities Act. If the selling stockholders are deemed
to be
underwriters, the selling stockholders may be subject to certain statutory
and
regulatory liabilities, including liabilities imposed pursuant to Sections
11,
12 and 17 of the Securities Act and Rule 10b-5 under the Exchange
Act.”
QUESTION
10:
Are
their
specific individuals who have voting or investment control over the
securities?
ANSWER:
Yes
______ No______
If
you
answered “yes”, please list the names of such individuals:
The
answers to the foregoing questions are true and correct to the best of the
undersigned’s knowledge, information and belief. The undersigned agrees to
promptly notify the Company in writing in care of Chief Financial Officer,
InSite Vision Incorporated, 000 Xxxxxxxx Xxxxxx, Xxxxxxx, Xxxxxxxxxx 00000
of
(a) any transfer by you of your Securities, (b) sales of common stock of the
Company (giving the number of shares sold and the name of the broker-dealer
used) and (c) any other changes in the answers to this questionnaire that should
be made as a result of any material development occurring subsequent to the
date
hereof.
37
Dated:
December 30, 2005.
____________________________________
Signature
The
undersigned is informed of the significance to the Company of the foregoing
representations and answers contained in the Confidential Subscriber
Questionnaire contained in this Article VIII and such answers have been provided
under the assumption that the Company will rely on them.
[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]
[SIGNATURE
PAGE TO FOLLOW]
38
[Signature
Page]
$____________
Closing
Amount
(Aggregate Principal Amount of Notes Purchased)
|
|
_____________
(Number of Warrants Granted)
|
|
_____________________
Signature
of Subscriber
|
________________________________
Signature
of Subscriber (if purchasing jointly)
|
_____________________
Name
Typed or Printed
|
________________________________
Name
Typed or Printed
|
_____________________
Entity
Name
|
________________________________
Entity
Name
|
_____________________
Title
|
________________________________
Title
|
_____________________
Address
|
________________________________
Address
|
_____________________
City,
State and Zip Code
|
________________________________
City,
State and Zip Code
|
_____________________
Telephone-Business
|
________________________________
Telephone--Business
|
_____________________
Telephone-Residence
|
________________________________
Telephone--Residence
|
_____________________
Facsimile-Business
|
________________________________
Facsimile--Business
|
_____________________
Facsimile-Residence
|
________________________________
Facsimile—Residence
|
_____________________
Tax
ID # or Social Security #
|
________________________________
Tax
ID # or Social Security #
|
Name
in
which securities should be issued: _________________________
Dated: December
30, 2005
This
Subscription Agreement is agreed to and accepted by the Company as of December
30, 2005.
INSITE
VISION INCORPORATED
By:____________________________________
Name:
X.
Xxxxx
Xxxxxxxxxxxxxx, Ph. D.
Title: President
and Chief Executive Officer
39
CERTIFICATE
OF SIGNATORY
(To
be
completed if Notes and Warrants are
being
subscribed for by an entity)
I,____________________________,
am the____________________________ of __________________________________________
(the “Entity”).
I
certify
that I am empowered and duly authorized by the Entity to execute and carry
out
the terms of the Subscription Agreement and to purchase and hold the Notes
and
Warrants offered hereunder, and certify further that the Subscription Agreement
has been duly and validly executed on behalf of the Entity and constitutes
a
legal and binding obligation of the Entity.
IN
WITNESS WHEREOF, I have set my hand this ______ day of _________________,
2005.
_______________________________________
Signature)
40
Exhibit
A
Form
of
Note
41
Exhibit
B
Form
of
Warrant
42
Exhibit
C
Form
of
Security/Intercreditor Agreement
43
Exhibit
D
Notice
to Subscriber
of
Subscriber
Amount
Dear
Subscriber:
Pursuant
to the Section 1.2 of that certain Subscriber Agreement by and between InSite
Vision Incorporated and certain signatories therein, dated as of December 30,
2005 (the “Subscription Agreement”), this letter shall serve as notice to
provide you with information concerning your allocation for the Closing in
connection with the Offering of Notes and Warrants by the Company and the amount
you are hereby obligated to invest at the Closing per the Subscription Agreement
(the “Closing Amount” as further defined in the Subscription
Agreement).
A) Subscriber’s subscription amount: | ______________ | |
B)
Aggregate Principal Amount of Notes
Available to all Subscribers
for
Closing:
|
______________ | |
C)
Aggregate Principal Amount of Notes
Allocated to you for
Closing:
|
______________ | |
D) Warrants Allocated to you at Closing | ______________ | |
(expressed
in shares of Common Stock
issuable
upon exercise of such Warrants)
|
||
E) Closing Amount due at Closing: | ______________ |
44